Oculis Holding AG
Privosegtor
optic neuritis
Countdown
177days
Phase 2 readout · ~ Dec 31, 2026 estimated
What's at stake
Phase 2 trial results for Privosegtor in optic neuritis are due ~ Dec 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 12h ago
“topline results are expected around the end of 2026.”